Aging concept stocks for your reference:
1. Jianfan Biotechnology (300529): According to the "High-tech Enterprises" jointly issued by the Ministry of Science and Technology, the Ministry of Finance, and the State Administration of Taxation "Recognition Management Measures" and its annex "High-tech Fields Supported by the State", the company's industry is the medical device industry in the biopharmaceutical industry.
2. Hisun Pharmaceutical (600267): The company has patents for anti-Alzheimer’s products.
3. HiSilicon (002653): For the pharmaceutical industry, 2016 is a year of both challenges and opportunities: the intensity and progress of pharmaceutical reform exceeded expectations. From the R&D and production level, drug registration and clinical data Self-inspections, unannounced inspections, and price reductions in local pharmaceutical tenders in the drug circulation link have increased the compliance costs of pharmaceutical companies, and their growth rates have faced greater challenges; but on the other hand, the aging of the population has intensified, the medical insurance system has continued to improve, and the The liberalization of child care policies and the increasing health awareness of residents have brought opportunities for the continued expansion of the pharmaceutical market. Policy reforms such as hierarchical diagnosis and treatment, Internet +, and precision medicine plans have brought vitality to the traditional pharmaceutical industry; with the supply-side structure in the industry With the continuous deepening of sexual reform, industry concentration will be improved, which is conducive to the long-term and stable development of the entire industry.
4. Yunnan Baiyao (000538): The pharmaceutical industry has always been a pillar industry driving economic growth in my country. According to the relevant national development plan, it will maintain medium-to-high growth during the 13th Five-Year Plan period.
5. Hengrui Medicine (600276): The company is the largest research and production base for anti-tumor drugs and surgical drugs in China, and one of the backbone enterprises of the National Torch Plan new drug research, development and industrialization base. "National 863 Program Achievements Industrialization Base".
Warm reminder: The above content is for reference only and does not make any recommendations. Investment is risky, so be cautious when entering the market.
Response time: 2021-05-14. For the latest business changes, please refer to the official website of Ping An Bank.
[I know about Ping An Bank] Want to know more? Come and take a look at "I Know Ping An Bank"~
/paim/iknow/index.html